Lumentum's 25% Slide Tests a Valuation Built on Scarcity
Lumentum fell 25% in five sessions even as AI-related optical demand remained strong. The selloff exposed how much future growth was already embedded in a price-to-sales multiple above 20.
Lumentum lost about a quarter of its market value in five trading sessions even though the company did not announce a collapse in demand. The move was a valuation reset in an AI supplier whose shares had risen faster than its already rapid operating growth.
The fundamental case remains unusually strong. Lumentum's official fiscal fourth-quarter release reported $1.01 billion of revenue, up 109% from a year earlier. The company guided the following quarter to $1.225 billion to $1.275 billion, while demand for optical components used in data centers continued to exceed available supply.
The reported $7.2 billion quarterly net loss needs context. Lumentum said it was driven by a $7.8 billion non-cash loss from debt extinguishment associated with the equitization of convertible notes. Operating performance moved in the opposite direction: GAAP operating margin reached roughly 28%, and non-GAAP earnings were positive.
The stock's vulnerability came from price. Even after the decline, the source analysis put Lumentum at more than 23 times trailing sales, versus roughly three times for the S&P 500. A sales multiple that high assumes strong growth and margins will persist for years. It leaves little room for slower cloud spending, manufacturing delays or customer concentration.
The October selloff also hit CoreWeave, Nebius and other AI-linked infrastructure names, suggesting that investors were reducing exposure to the entire capital-spending chain. That does not make every company identical. Lumentum sells scarce optical components into expanding networks, while leveraged cloud builders face different financing risks.
Investors should judge the next report on revenue delivery, operating margin and capacity expansion rather than on the one-time accounting loss. The more difficult question is valuation: if supply constraints ease, the market may award a lower multiple even while sales keep growing.
Lumentum's demand evidence survived the selloff. Its valuation cushion did not. The next quarter must show that revenue and cash earnings are catching up fast enough to support a price that still discounts several years of AI-network growth.